Trials should also incorporate sex-specific analyses, age related stratification, and clinically relevant comorbidities such as gastrointestinal dysfunction and sleep problems, all of which can modulate treatment efficacy
Modulation of inflammatory mediators: I3C treatment has been shown to decrease the expression of pro-inflammatory factors like IL-1 and IL-6 while increasing anti-inflammatory factors such as IL-4 and IL-10
Sharp pain may begin transitioning to duller discomfort
Claims that BPC 157 increases testosterone remain speculative and anecdotal
hence, many disorders are followed as the inevitable ramifications (Reference Chen, Deng and Cui3)
Its ability to cross the blood-brain barrier means it plays an important role in helping remove toxins, such as mercury, from the brain and other cells